Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Codexis to Hold 2017 Third Quarter Conference Call on November 9

Posted on: 02 Nov 17

REDWOOD CITY, Calif, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report third quarter 2017 financial results after market close on Thursday, November 9, 2017. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss financial results and provide a company update. 

Live Call:  U.S.  855 890 8665
   International  720 634 2938
   Passcode  5797258
Live Webcast:  Codexis IR Website   
   The webcast will be archived for 30 days.
Replay:  U.S.  855 859 2056
   International  404 537 3406
   Passcode  5797258
   The replay will be available for 48 hours

About Codexis, Inc.
Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for commercial manufacture of pharmaceuticals and fine chemicals, as well as the development of enzymes as biotherapeutics and for molecular diagnostics. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see


LHA Investor Relations
Jody Cain, 310 691 7100


Last updated on: 02/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.